Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In lyophilized form, no
Trimethylamine hydrochloride (CAS 593-81-7), TMAO (CAS 1184-78-7), -butyrobetaine [-BB, commercially available as 3-(Carboxypropyl)trimethylammonium chloride, CAS 6249-56-5], urolithin A (CAS 1143-70-0), urolithin B (CAS 1139-83-9), ellagic acid (CAS 476-66-4), trichloroacetic acid, dimethyl sulfoxide, glacial acetic acid, sulfatase (CAS 9016-17-5), -glucuronidase (CAS 9001-45-0), and heptafluorobutyric acid were purchased from Merck (Darmstadt, Germany)
mRS, modified rankin scale
Drug Test Anal
Intravenous autologous BMMNC therapy in subacute stroke was feasible but did not show uniform efficacy [36]
US$ 25.82
US$ 20.46
US$ 25.03
US$ 24.61
US$ 28.58
US$ 21.89
